Evelo Biosciences, Inc. - EVLO

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2023 · Q2 2023
Value (USD)
Total reported value ($000)
$13.59M
QoQ value delta ($000)
+$11.58M (+577.99%)
Implied price effect (QoQ)
+21.01%
Shares
Total shares
3,468,012
QoQ shares delta
+2,849,040 (+460.29%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (EVLO)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2023)

Top 25 only Full list
Early Q4 2023 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
FMR LLC 9,589 2,446,390 0.0%
VANGUARD GROUP INC 1,402 357,711 0.0%
Alyeska Investment Group, L.P. 1,039 265,103 0.01%
STATE OF MICHIGAN RETIREMENT SYSTEM 797 203,536 0.01%
GEODE CAPITAL MANAGEMENT, LLC 254 64,823 0.0%
MILLENNIUM MANAGEMENT LLC 149 38,093 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 104 26,679 0.0%
MORGAN STANLEY 89 22,765 0.0%
NORTHERN TRUST CORP 71 18,200 0.0%
BARCLAYS PLC 46 11,755 0.0%
Tower Research Capital LLC (TRC) 13 3,453 0.0%
JPMORGAN CHASE & CO 12 3,162 0.0%
BANK OF AMERICA CORP /DE/ 10 2,789 0.0%
CITIGROUP INC 7 1,872 0.0%
UBS Group AG 3 923 0.0%
ROYAL BANK OF CANADA 2 505 0.0%
WELLS FARGO & COMPANY/MN 0 52 0.0%
PNC FINANCIAL SERVICES GROUP, INC. 0 180 0.0%
NATIONAL BANK OF CANADA /FI/ 0 5 0.0%
GROUP ONE TRADING, L.P. 0 16 0.0%